Publications by authors named "Matthew Sobo"

Claim this Profile
L
Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma.
Satarupa Sengupta, Shiva Senthil Kumar, Kathryn Bondra, Matthew Sobo, Xiaokui Mo

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Satarupa Sengupta, Matthew Sobo, Kyungwoo Lee, Shiva Senthil Kumar, Angela R White

Mol Cancer Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Trent R Hummel, Ralph Salloum, Rachid Drissi, Shiva Kumar, Matthew Sobo

J Neurooncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
Kathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, Eshini Panditharatna, Charles B Stevenson

J Neurooncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
Li Lin, Brian Hutzen, Pui-Kai Li, Sarah Ball, Mingxin Zuo, Matthew Sobo

Neoplasia· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
Brian Hutzen, Lauren Friedman, Matthew Sobo, Li Lin, Ling Cen

Int J Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
Li Lin, Brian Hutzen, Sarah Ball, Elizabeth Foust, Matthew Sobo

Cancer Sci· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis